| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | antigen binding | IGHV3-38 IGHV3-23 IGHV4-61 IGHV4-59 IGHV4-30-4 IGHV3-38-3 IGHV1-18 | 7.52e-08 | 190 | 39 | 7 | GO:0003823 |
| GeneOntologyBiologicalProcess | immunoglobulin mediated immune response | IGHV3-38 C5 IGHV3-23 IGHV4-61 IGHV4-59 IGHV4-30-4 IGHV3-38-3 IGHV1-18 | 1.14e-08 | 235 | 39 | 8 | GO:0016064 |
| GeneOntologyBiologicalProcess | B cell mediated immunity | IGHV3-38 C5 IGHV3-23 IGHV4-61 IGHV4-59 IGHV4-30-4 IGHV3-38-3 IGHV1-18 | 1.53e-08 | 244 | 39 | 8 | GO:0019724 |
| GeneOntologyBiologicalProcess | lymphocyte mediated immunity | IGHV3-38 C5 IGHV3-23 SH2D1A IGHV4-61 IGHV4-59 IGHV4-30-4 IGHV3-38-3 IGHV1-18 | 1.20e-07 | 449 | 39 | 9 | GO:0002449 |
| GeneOntologyBiologicalProcess | leukocyte mediated immunity | IGHV3-38 C5 IGHV3-23 SH2D1A IGHV4-61 IGHV4-59 IGHV4-30-4 IGHV3-38-3 IGHV1-18 | 9.73e-07 | 576 | 39 | 9 | GO:0002443 |
| GeneOntologyBiologicalProcess | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | IGHV3-38 C5 IGHV3-23 IGHV4-61 IGHV4-59 IGHV4-30-4 IGHV3-38-3 IGHV1-18 | 1.99e-06 | 462 | 39 | 8 | GO:0002460 |
| GeneOntologyBiologicalProcess | adaptive immune response | IGHV3-38 C5 IGHV3-23 SH2D1A IGHV4-61 IGHV4-59 IGHV4-30-4 IGHV3-38-3 IGHV1-18 | 2.04e-05 | 838 | 39 | 9 | GO:0002250 |
| GeneOntologyBiologicalProcess | immune effector process | IGHV3-38 C5 IGHV3-23 SH2D1A IGHV4-61 IGHV4-59 IGHV4-30-4 IGHV3-38-3 IGHV1-18 | 2.48e-05 | 859 | 39 | 9 | GO:0002252 |
| GeneOntologyCellularComponent | immunoglobulin complex | IGHV3-38 IGHV3-23 IGHV4-61 IGHV4-59 IGHV4-30-4 IGHV3-38-3 IGHV1-18 | 2.18e-08 | 166 | 39 | 7 | GO:0019814 |
| HumanPheno | Narrow nasal tip | 1.27e-05 | 3 | 11 | 2 | HP:0011832 | |
| Domain | fn3 | 2.64e-03 | 162 | 32 | 3 | PF00041 | |
| Domain | FN3 | 3.84e-03 | 185 | 32 | 3 | SM00060 | |
| Domain | FN3 | 4.71e-03 | 199 | 32 | 3 | PS50853 | |
| Domain | FN3_dom | 5.39e-03 | 209 | 32 | 3 | IPR003961 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 4.84e-06 | 60 | 27 | 4 | MM14872 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 1.85e-05 | 84 | 27 | 4 | MM14653 | |
| Pathway | REACTOME_CD22_MEDIATED_BCR_REGULATION | 3.94e-05 | 35 | 27 | 3 | MM17219 | |
| Pathway | REACTOME_CLASSICAL_ANTIBODY_MEDIATED_COMPLEMENT_ACTIVATION | 5.47e-05 | 39 | 27 | 3 | MM17212 | |
| Pathway | REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION | 8.43e-05 | 45 | 27 | 3 | MM14912 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 1.02e-04 | 48 | 27 | 3 | MM17214 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 1.38e-04 | 53 | 27 | 3 | MM15716 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 1.46e-04 | 54 | 27 | 3 | MM14655 | |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | 1.62e-04 | 56 | 27 | 3 | MM14815 | |
| Pathway | REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION | 1.80e-04 | 58 | 27 | 3 | MM14914 | |
| Pathway | REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION | 1.99e-04 | 60 | 27 | 3 | MM14913 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 2.18e-04 | 158 | 27 | 4 | MM14812 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 8.44e-04 | 98 | 27 | 3 | M27152 | |
| Pathway | REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION | 1.09e-03 | 107 | 27 | 3 | MM14915 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | 1.16e-03 | 645 | 27 | 6 | MM15232 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 1.31e-03 | 114 | 27 | 3 | MM14814 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 1.34e-03 | 115 | 27 | 3 | M19752 | |
| Pathway | REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR | 1.95e-03 | 131 | 27 | 3 | MM15717 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 2.12e-03 | 135 | 27 | 3 | MM14781 | |
| Pubmed | IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes. | 1.72e-06 | 77 | 39 | 4 | 15608191 | |
| Pubmed | Early onset of somatic mutation in immunoglobulin VH genes during the primary immune response. | 1.98e-06 | 22 | 39 | 3 | 2499654 | |
| Pubmed | Prelamin A causes aberrant myonuclear arrangement and results in muscle fiber weakness. | 7.34e-06 | 4 | 39 | 2 | 30282816 | |
| Pubmed | 1.16e-05 | 39 | 39 | 3 | 8490662 | ||
| Pubmed | 1.67e-05 | 44 | 39 | 3 | 31273033 | ||
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 31142202 | ||
| Pubmed | Cloning, sequencing and expression of the rearranged MOPC 315 VH gene segment. | 2.56e-05 | 7 | 39 | 2 | 2497341 | |
| Pubmed | 2.56e-05 | 7 | 39 | 2 | 3937730 | ||
| Pubmed | Model-building studies of antigen-binding sites: the hapten-binding site of mopc-315. | 2.56e-05 | 7 | 39 | 2 | 268248 | |
| Pubmed | 2.56e-05 | 7 | 39 | 2 | 2587273 | ||
| Pubmed | Amino acid sequence of the precursor region of MOPC-315 mouse immunoglobulin heavy chain. | 2.56e-05 | 7 | 39 | 2 | 414225 | |
| Pubmed | A new germline VH36-60 gene is used in the neonatal primary and adult memory response to (T,G)-A--L. | 2.56e-05 | 7 | 39 | 2 | 1683681 | |
| Pubmed | 2.56e-05 | 7 | 39 | 2 | 4524622 | ||
| Pubmed | Structure and function of immunoglobulin genes and precursors. | 5.48e-05 | 10 | 39 | 2 | 428562 | |
| Pubmed | 8.03e-05 | 12 | 39 | 2 | 17938243 | ||
| Pubmed | Wnt/beta-catenin signaling is required for development of the exocrine pancreas. | 9.48e-05 | 13 | 39 | 2 | 17222338 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 1.27e-04 | 1024 | 39 | 7 | 24711643 | |
| Pubmed | 1.46e-04 | 16 | 39 | 2 | 9851981 | ||
| Pubmed | The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus. | 1.48e-04 | 91 | 39 | 3 | 9841928 | |
| Pubmed | 1.65e-04 | 17 | 39 | 2 | 32350257 | ||
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 3.05e-04 | 289 | 39 | 4 | 23752268 | |
| Pubmed | 3.33e-04 | 24 | 39 | 2 | 19680556 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | 3.40e-04 | 1203 | 39 | 7 | 29180619 | |
| Pubmed | 3.91e-04 | 26 | 39 | 2 | 25186293 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 5.93e-04 | 146 | 39 | 3 | 23892456 | |
| Pubmed | 7.54e-04 | 36 | 39 | 2 | 6690234 | ||
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 8.90e-04 | 168 | 39 | 3 | 30631154 | |
| Pubmed | MITOL regulates phosphatidic acid-binding activity of RMDN3/PTPIP51. | 9.77e-04 | 41 | 39 | 2 | 34964862 | |
| Pubmed | 9.85e-04 | 174 | 39 | 3 | 32149426 | ||
| Pubmed | 1.03e-03 | 42 | 39 | 2 | 37353485 | ||
| Pubmed | TRIM6 promotes colorectal cancer cells proliferation and response to thiostrepton by TIS21/FoxM1. | 1.07e-03 | 43 | 39 | 2 | 31992359 | |
| Cytoband | 14q32.33 | IGHV3-38 IGHV3-23 IGHV4-61 IGHV4-59 IGHV4-30-4 IGHV3-38-3 IGHV1-18 | 9.13e-10 | 228 | 39 | 7 | 14q32.33 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q32 | 1.14e-04 | 566 | 39 | 5 | chr14q32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q33 | 6.18e-03 | 138 | 39 | 2 | chr9q33 | |
| GeneFamily | Immunoglobulin heavy locus at 14q32.33 | IGHV3-38 IGHV3-23 IGHV4-61 IGHV4-59 IGHV4-30-4 IGHV3-38-3 IGHV1-18 | 8.44e-09 | 187 | 27 | 7 | 349 |
| GeneFamily | Fibronectin type III domain containing | 1.70e-03 | 160 | 27 | 3 | 555 | |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell-IgM_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.55e-07 | 166 | 37 | 5 | 2b7b580bec8d9467b0deaf97098065f72dbf2a4f | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.50e-07 | 177 | 37 | 5 | 4c434a7b7cc54cf4dac996bbc3f5124d9ef9a9cd | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.50e-07 | 177 | 37 | 5 | fc40918825b7e1eb6861df59dfca944778a64b98 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.50e-07 | 177 | 37 | 5 | d746122bf8d208c3aa4d156e8c12d0a0e555c6e5 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.71e-07 | 179 | 37 | 5 | 837ed81f18257f444eaeadc4fac89deedd4e3061 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.71e-07 | 179 | 37 | 5 | 494febe77c6d4e6a2c6f0928bbf4c84b0301f188 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.71e-07 | 179 | 37 | 5 | b6ee4f41d8fb5f047b7bdd8489dda0a89fc6d43f | |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell-IgA_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass | 4.48e-07 | 186 | 37 | 5 | e2c050ba02e1f84f0b7258dc92e7ff6ab349ff67 | |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 4.72e-07 | 188 | 37 | 5 | bd53b0371154cff680226897b61c9809a239d1b6 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.38e-07 | 193 | 37 | 5 | 34f6c13884fdf7f8a87f942fcb36a58cfac3f65d | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.52e-07 | 194 | 37 | 5 | 6ef4aeb8d8e35e4df58ff2a8256caa2113291de9 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.66e-07 | 195 | 37 | 5 | f3f7f1a77a1edd2b50a8211c76fe289738eb04cf | |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell-IgM_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass | 5.80e-07 | 196 | 37 | 5 | 026a06d8d2089806823e6f6453d3ede84ae93bc6 | |
| ToppCell | metastatic_Brain-B_lymphocytes-Plasma_cells|metastatic_Brain / Location, Cell class and cell subclass | 1.18e-05 | 170 | 37 | 4 | 53634da9e9c72f6400639954c286c6e38ea5a188 | |
| ToppCell | metastatic_Brain-B_lymphocytes-MALT_B_cells|metastatic_Brain / Location, Cell class and cell subclass | 1.35e-05 | 176 | 37 | 4 | 50e207403d48ce1b55a78897adb5519a2430a626 | |
| ToppCell | Control-Lymphoid_P|Control / Disease group, lineage and cell class | 1.35e-05 | 176 | 37 | 4 | d895a6b295cd649273ff80ad7785a3e0ae4c728a | |
| ToppCell | Control-Lymphoid_P-Plasmablast|Control / Disease group, lineage and cell class | 1.35e-05 | 176 | 37 | 4 | 4b4416f342b732d2cc60133838728880326257d8 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.41e-05 | 178 | 37 | 4 | 107dae8b00c4257697a63700e72bb434cdb8406f | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.44e-05 | 179 | 37 | 4 | 56db12467b445f2b8ef92af50779eeab10413eb2 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.48e-05 | 180 | 37 | 4 | e3877f6ef5f54ff689058b4c996ab1851822f871 | |
| ToppCell | BAL-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.48e-05 | 180 | 37 | 4 | 6a777a308fa3160d31eda468db930e71862020b2 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.51e-05 | 181 | 37 | 4 | f7b08f662eb77ee7a777c6525ddc3195046aaf65 | |
| ToppCell | cellseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.57e-05 | 183 | 37 | 4 | 5ab4aa0304b832f98fff89b6c24ad5b7dd014c11 | |
| ToppCell | 10x5'-Liver-Lymphocytic_B_plasma-Plasma_cells|Liver / Manually curated celltypes from each tissue | 1.61e-05 | 184 | 37 | 4 | 6f70d8f8ab8362d51f8a58735d42223e06566397 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-05 | 185 | 37 | 4 | 08bc817908076734d66f2805cb954141f2cc5a18 | |
| ToppCell | metastatic_Brain-B_lymphocytes|metastatic_Brain / Location, Cell class and cell subclass | 1.64e-05 | 185 | 37 | 4 | 153b82dc5ace03f84dc82d724d56bdc93aa020df | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-05 | 185 | 37 | 4 | 6ec009e48e50471c28e914c402f500e56a88f8f2 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-05 | 185 | 37 | 4 | 0fff2608f507e019ebb69c27e58fd5be3b049bef | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-05 | 185 | 37 | 4 | 79edc1eeb7b5b9123961ac3ecf398ee68d9dddb9 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-05 | 185 | 37 | 4 | f49ad6401b2abd089e30eba245b11b5031ea2318 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-05 | 185 | 37 | 4 | 1704a12153a9b107bf03ecccd1a036cf61334d7a | |
| ToppCell | 10x5'-Liver-Lymphocytic_B_plasma|Liver / Manually curated celltypes from each tissue | 1.68e-05 | 186 | 37 | 4 | a2c7430781f432c9c90ac4d620f4518ff767a223 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-B_lymphocytic-plasma_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.71e-05 | 187 | 37 | 4 | c80e03d5aa498b4eecbc46565fabf9b5be10c71c | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.79e-05 | 189 | 37 | 4 | ca3a04c202afc32aa11d17154066ef7dc6d01405 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.82e-05 | 190 | 37 | 4 | 79ee6d10dfbb775da149a1104da5823cf63bbb46 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.82e-05 | 190 | 37 | 4 | 18762ce78ed0b206ade19e1c8ff76a2647489f68 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.86e-05 | 191 | 37 | 4 | d1d30279ed4612b4f62c225d9eabf0b8a7a09d11 | |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell-IgM_Plasmablast|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.94e-05 | 193 | 37 | 4 | 7b4b0271e4fbece703876acb053ae236afb7cdba | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.94e-05 | 193 | 37 | 4 | 282b47dae6043eabb1e13d41d91c07b5ec21cd65 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Paneth|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.98e-05 | 194 | 37 | 4 | 2f6e62a4ec8707bd5a16c0734c5131af55207ea2 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.98e-05 | 194 | 37 | 4 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.98e-05 | 194 | 37 | 4 | a4a70369541876e1192df8828b63e3d1746ae3d9 | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.02e-05 | 195 | 37 | 4 | df009b18898c10686f75cf72b4ec0eff18f5bb50 | |
| ToppCell | Biopsy_IPF-Immune-Plasma_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 2.06e-05 | 196 | 37 | 4 | a1b6a8000b86efcb07843998aa3a49bb1f54bcda | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-05 | 196 | 37 | 4 | fec21383435779bf4c632decd3d29c6ca7baebfb | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.10e-05 | 197 | 37 | 4 | 88b29d205237f07a9a26cc15a1cf4ed4816a4c4b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.10e-05 | 197 | 37 | 4 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell-IgA_Plasmablast|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.10e-05 | 197 | 37 | 4 | fdbf4eb9fa5aefb4ffb307494fe4774bf5e0aaeb | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.10e-05 | 197 | 37 | 4 | 9fe1b757f76c2d43d39aa9ac500eaba98723985c | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_cell-B_naive|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.14e-05 | 198 | 37 | 4 | 79c690d21d3420d0bb1a3b3b4ea2c9aa3810a219 | |
| ToppCell | Control-Control-Lymphocyte-B-Plasmablast|Control / Disease, condition lineage and cell class | 2.19e-05 | 199 | 37 | 4 | c11aa8bca3723a886e7082ae48bb922dd8396be4 | |
| ToppCell | Sigmoid-(1)_T_cell-(16)_Tfh|Sigmoid / shred on region, Cell_type, and subtype | 2.19e-05 | 199 | 37 | 4 | a61bf52d2d359746433623ee00337124f1f84f61 | |
| ToppCell | Sigmoid-T_cell-Tfh|Sigmoid / Region, Cell class and subclass | 2.19e-05 | 199 | 37 | 4 | fa9404a021a015d1d571c324780b6eef2da47c4c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-04 | 146 | 37 | 3 | 281144e293e8c93a425c2606d2188cb2838e667f | |
| ToppCell | P15-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.45e-04 | 147 | 37 | 3 | aba44c7057096483c4293a7ebcf8ccc8baed0231 | |
| ToppCell | droplet-Liver-Npc-21m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-04 | 155 | 37 | 3 | 5d600e159738231d0607ea1a1ebd8510fc241b36 | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-C_(Capillary_Aerocyte_)|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.97e-04 | 157 | 37 | 3 | 84f629b7f589ca8a1abc220fa740c4a6fdc1b579 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC1|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.02e-04 | 158 | 37 | 3 | c276a259e20ee704e2d04baf693e8d677f96f654 | |
| ToppCell | normal_Lung-B_lymphocytes-MALT_B_cells|normal_Lung / Location, Cell class and cell subclass | 3.08e-04 | 159 | 37 | 3 | fbd0131b66f4267f7b0d6c3ad874ad097b859074 | |
| ToppCell | droplet-Liver-Npc-21m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-04 | 160 | 37 | 3 | 85205dc68369d3e04df3460c1f3861ee2dc242a9 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.20e-04 | 161 | 37 | 3 | d72c572613f8eff3251cb7b1e9dcc76d193b2f21 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B_plasma-Plasma_cells|Lung / Manually curated celltypes from each tissue | 3.37e-04 | 164 | 37 | 3 | 3b6a32ba53d05f6818fe950ac426f489383b645a | |
| ToppCell | 3'_v3-blood-Lymphocytic_B_plasma-Plasma_cells|blood / Manually curated celltypes from each tissue | 3.43e-04 | 165 | 37 | 3 | 1c0c24fe252b761cf879b83562e23c02f0b6489f | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-Enterocyte_(Proximal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-04 | 165 | 37 | 3 | ce79d217df88035457cd58f679e72dd98722ae22 | |
| ToppCell | 390C-Lymphocytic-Plasma_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.49e-04 | 166 | 37 | 3 | 4ba3711a02d3695b27f7cefd7c60e3be009f5bef | |
| ToppCell | 390C-Lymphocytic-Plasma_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.49e-04 | 166 | 37 | 3 | 35f6ae2664935dda0d883b32a050ced843204f2d | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-mature_enterocytic-Paneth|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.49e-04 | 166 | 37 | 3 | b64ab3d13b76bba3c305ebbfc96f983cd6ca30c9 | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.62e-04 | 168 | 37 | 3 | 03c95ad3684caec7a6d581006b237cc5fa230685 | |
| ToppCell | 10x5'-GI_large-bowel|World / Manually curated celltypes from each tissue | 3.62e-04 | 168 | 37 | 3 | 1290c909655bc37f6b8bf216d18127a21b99e9c0 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B_plasma|Lung / Manually curated celltypes from each tissue | 3.68e-04 | 169 | 37 | 3 | a65853ff9f6489cc1617cbba0d03b392d23c1528 | |
| ToppCell | BAL-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.68e-04 | 169 | 37 | 3 | 307571e57c3bfdf15f0fe1a8b36585e8e4f8a207 | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-04 | 169 | 37 | 3 | b798b91567d2f49082e2d8a337169f241c8d2080 | |
| ToppCell | BAL-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.68e-04 | 169 | 37 | 3 | 9ab34f602d46ce87283d243b81621e8806504f43 | |
| ToppCell | BAL-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.68e-04 | 169 | 37 | 3 | 89fbafdb4628ce7a90c50398870e0f8ee90cfd91 | |
| ToppCell | BAL-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.68e-04 | 169 | 37 | 3 | 75d367eb35768d3063096e8866cea649dac3b1bd | |
| ToppCell | BAL-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.75e-04 | 170 | 37 | 3 | 7dcb6319ba4d7b258dd0a17449d837800ef46ccc | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.75e-04 | 170 | 37 | 3 | 054360a3b05f5e41221c98b122d241b1affad26a | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell-B_activate-7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.75e-04 | 170 | 37 | 3 | ee2ee67d90ae4596de8ccd620e37c82cf51651d4 | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.75e-04 | 170 | 37 | 3 | d7ca0c6ce5d2b7de99346f87e07aa7fe728fa08a | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.75e-04 | 170 | 37 | 3 | 52787f6d529c285d9f0c04cc022710ead5b89b3f | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.75e-04 | 170 | 37 | 3 | d0ed3a8a7ad96c05641ec409b0a69c4fb094893c | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-04 | 170 | 37 | 3 | 75b0486620cab838d3feb1c3aa965b487a906618 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.75e-04 | 170 | 37 | 3 | f0b0d2d0402de3ed7322284a599646db43475761 | |
| ToppCell | BAL-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.75e-04 | 170 | 37 | 3 | 7377e59fba4bf97ba893ccf6b5e149b5152407be | |
| ToppCell | BAL-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.75e-04 | 170 | 37 | 3 | e18211029e9ffad54458fd921f455172aad407c7 | |
| ToppCell | E12.5-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.81e-04 | 171 | 37 | 3 | a4d6b0f57eead11b01153688b06b2a45a3b488f2 | |
| ToppCell | Control-B_cell-Plasmablast|Control / Disease group,lineage and cell class (2021.01.30) | 3.81e-04 | 171 | 37 | 3 | c09afc4b111b2b5acca75177554f6364ee02d37c | |
| ToppCell | 10x5'-Lung-Lymphocytic_B_plasma|Lung / Manually curated celltypes from each tissue | 3.88e-04 | 172 | 37 | 3 | 8156fb6de66a4c92ade703b71c2e9187291e50ef | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.88e-04 | 172 | 37 | 3 | afa36501d48b1456c511fa0d5d326ec05bdc380f | |
| ToppCell | 5'-Adult-Distal_Rectal-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.94e-04 | 173 | 37 | 3 | 09cd878c33534bd476d6a4880f5582076189da8c | |
| ToppCell | 5'-Adult-Distal_Rectal-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.94e-04 | 173 | 37 | 3 | 62abaaaf48cabd1423f17fb27c33b75ea88867f4 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.94e-04 | 173 | 37 | 3 | 7e6bfe85f60834f317941b70d6e0dc3bd527d293 | |
| ToppCell | Plasma_cells|World / lung cells shred on cell class, cell subclass, sample id | 3.94e-04 | 173 | 37 | 3 | 52a387e2a4694af61a9223a4c2ecf4e6f762c064 | |
| ToppCell | E17.5-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.01e-04 | 174 | 37 | 3 | 68914ec843f58ecff3e6412544a341daf8a01cac | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.01e-04 | 174 | 37 | 3 | c529f3674b784f872f4387ffdeb46aecb619976b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.15e-04 | 176 | 37 | 3 | dc5a22f9d1347f157bdd93e6e5769b983deccf1a | |
| ToppCell | Int-URO-Lymphocyte-T_NK-gdT|Int-URO / Disease, Lineage and Cell Type | 4.15e-04 | 176 | 37 | 3 | 15016a73c953d8d3e7c32a05ead5e7261f9914ca | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-04 | 176 | 37 | 3 | 7622f5a8e7320cc7b593141854107ecaf4adff7f | |
| ToppCell | IPF-Lymphoid-B_Plasma|IPF / Disease state, Lineage and Cell class | 4.15e-04 | 176 | 37 | 3 | e4f33f6cd140dd4fa3002bcd65ac8005d27865d1 | |
| ToppCell | BAL-Control-Lymphocyte-B|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.15e-04 | 176 | 37 | 3 | 7c1ecec45b5fe5e73cbce0fadca726ffd10c0316 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 7.95e-05 | 12 | 33 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | free cholesterol to total lipids in large VLDL percentage | 7.88e-04 | 37 | 33 | 2 | EFO_0022281 | |
| Disease | Hypercholesterolemia | 8.76e-04 | 39 | 33 | 2 | C0020443 | |
| Disease | clinical treatment | 9.68e-04 | 41 | 33 | 2 | EFO_0007056 | |
| Disease | Neoplasm Invasiveness | 1.13e-03 | 184 | 33 | 3 | C0027626 | |
| Disease | triacylglycerol 54:4 measurement | 1.22e-03 | 46 | 33 | 2 | EFO_0010422 | |
| Disease | sexual dimorphism measurement | 1.27e-03 | 1106 | 33 | 6 | EFO_0021796 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 1.38e-03 | 49 | 33 | 2 | EFO_0022256 | |
| Disease | attention deficit hyperactivity disorder, bipolar disorder, autism spectrum disorder, schizophrenia, major depressive disorder | 1.49e-03 | 51 | 33 | 2 | EFO_0003756, EFO_0003888, MONDO_0002009, MONDO_0004985, MONDO_0005090 | |
| Disease | waist-hip ratio | 2.15e-03 | 1226 | 33 | 6 | EFO_0004343 | |
| Disease | CCL5 measurement | 2.34e-03 | 64 | 33 | 2 | EFO_0005117 | |
| Disease | feeling miserable measurement | 3.54e-03 | 79 | 33 | 2 | EFO_0009598 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DTSSYGYGDLFSDTW | 276 | Q5NDL2 | |
| TTGATYSYGPASWEA | 46 | O43823 | |
| AIYQASGSTIDWTYS | 356 | P15085 | |
| GVATSYAVWATSRSF | 126 | Q14728 | |
| SSLTLSWYGSSYDGG | 1346 | Q15746 | |
| VYYTLWSQFDEGSSS | 71 | P43362 | |
| WYDYSTGTSSTSTGQ | 1636 | Q2M2H8 | |
| WVSSISGGSTYYADS | 66 | A0A0C4DH36 | |
| WVSSISGGSTYYADS | 66 | P0DTE1 | |
| SSFYASCLSGEESYW | 1446 | Q14C86 | |
| GYVEAKSWTASSSYG | 101 | Q9Y4K0 | |
| CTVSGGSISSGDYYW | 41 | P0DP06 | |
| CTVSGGSVSSGSYYW | 41 | A0A0C4DH41 | |
| IRVATGSYSFTWTDG | 251 | Q9H4H8 | |
| SSSYGPYRSGSGWSS | 1021 | Q86YZ3 | |
| SSSYSPYGSGSGWSS | 1491 | Q86YZ3 | |
| SSSYSPYGSGSGWSS | 2431 | Q86YZ3 | |
| VGSIYWTAVTYGAVT | 106 | Q9NX47 | |
| VDYAICSSSSYWGST | 171 | Q9UNI1 | |
| CTVSGGSISSYYWSW | 41 | P01825 | |
| CKASGYTFTSYGISW | 41 | A0A0C4DH31 | |
| TYLAGVSGSTWAISS | 76 | Q9UP65 | |
| LYNWSASYSGGNTST | 1366 | P04114 | |
| ASSGLAFYSSTGWYN | 241 | A8MPY1 | |
| WARGSYSYVAAGSSG | 756 | O60341 | |
| WEVAYSGSATEYTFT | 621 | Q53EP0 | |
| NADYSYSVWKGGSAS | 1061 | P01031 | |
| RGAIYGSSWKYSTFS | 1106 | Q6IMN6 | |
| WVSAISGSGGSTYYA | 66 | P01764 | |
| TFSFWSGLYSETEGT | 76 | O75844 | |
| IYTYRVSQTETGSWS | 51 | O60880 | |
| ESSLSSYSDWYGSTH | 3711 | Q8NF91 | |
| TESSLWRSTDYGTTY | 226 | Q9UPU3 | |
| VATWYRVTFFGGSSS | 151 | Q8TER0 | |
| QFYTSLSYSGWGGSS | 256 | P54922 | |
| GSDGYYVALAWTSSA | 226 | O95070 | |
| SDYSSDYSDWTADAG | 846 | Q8WWQ0 | |
| GYYSSKSGWSSQSDY | 1241 | O15027 | |
| DISTGIYYGWASVGS | 41 | Q969G6 | |
| TYSTSVGDSFALEWS | 46 | Q96IQ7 | |
| RSPSWYKYTSTVSTG | 446 | Q86Y07 |